Tuberculosis treatment default among Brazilian children

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 8, 2006, Pages 864-869

  Da Silva Oliveira, Vera Lucia ^a,d   Da Cunha, A J L A ^b   Alves, R ^c  

^a Hospital Municipal Jesus   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVIX   (Brazil)

^d NONE   (Brazil)

Author keywords

Children; Default; Tuberculosis treatment

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; BRAZIL; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TUBERCULOSIS;

ADOLESCENT; ANTITUBERCULAR AGENTS; BCG VACCINE; BRAZIL; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HIV SEROPREVALENCE; HOSPITALIZATION; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PATIENT COMPLIANCE; PATIENT DROPOUTS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, LYMPH NODE; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 33746891510     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. World Health Organization. Stop TB. Tuberculosis and children. Geneva, Switzerland: WHO, 2004.
2. Cegielski J P, Chin D P, Espinal M A, et al. The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century. Infect Dis Clin North Am 2002; 16: 1-58.
3. World Health Organization. WHO Report 2003. Global Tuberculosis Control. Surveillance, planning, financing. WHO/CDS/2003.316. Geneva, Switzerland: WHO, 2003. http://www.who. int/gtb/publications/globrep/index.html. Accessed 5 February 2004.
4. Ministério da Saúde. IDB 2003. Indicadores de morbidade e fatores de risco. Taxa de incidência de tuberculose. Rio de Janeiro, Brazil: Ministério da Saúde, 2003. http://tabnet. datasus. gov.br/cgi/tabcgi.exe?idb2003/d0202.def. Accessed 18 July 2004.
5. Pacheco A G F, Soares E C C, Dias S M O, Cavalcante S C. Pediatric tuberculosis in Rio de Janeiro City, Brazil. [Abstract] Int J Tuberc Lung Dis 1999; 3 (Suppl 1): S192.
6. Caylà J A, Caminero J A, Rey R, Lara N, Vallés X, Galdós-Tangüis H, Working Group on Completion of Tuberculosis Treatment in Spain. Current status of treatment completion and fatality among tuberculosis patients in Spain. Int J Tuberc Lung Dis 2004; 8: 458-464.
7. Comolet T M, Rakotomalala R, Rajaonarioa H. Factors determining compliance with tuberculosis treatment in an urban environment, Tamatave, Madagascar. Int J Tuberc Lung Dis 1998; 2: 891-897.
8. Galdós-Tangüis H, Caylà J A, García de Ollala P, Jansà J M, Brugal M T. Factors predicting non-completion of tuberculosis treatment among HIV-infected patients in Barcelona (1987-1996). Int J Tuberc Lung Dis 2000; 4: 55-60.
9. Starke J R. Childhood tuberculosis: ending the neglect. Int J Tuberc Lung Dis 2002; 6: 373-374.
10. Alves R, Sant'Anna C C, da Cunha A J L A. Epidemiologia da tuberculose infantil na cidade do Rio de Janeiro, R J. Rev Saude Publica 2000; 34: 409-410.
11. Ussery X T, Valway S E, McKennam M, Cauthen G M, McCray E, Onorato I M. Epidemiology of tuberculosis among children in the United States: 1985-1994. Pediatr Infect Dis J 1996; 15: 697-704.
12. Starke J R. Resurgence of tuberculosis in children. Pediatr Pulmonol 1995; (Suppl 11): 16-17.
13. Eamranond J, Jaramillo E. Tuberculosis in children: reassessing the need for improved diagnosis in global control strategies. Int J Tuberc Lung Dis 2001; 5: 594-603.
14. Heymann S J, Brewer T F, Wilson M E, Colditz G A, Fineberg H V. Pediatric tuberculosis: what needs to be done to decrease morbidity and mortality. Pediatrics 2000; 106: E1.
15. Connolly C, Davies G R, Wilkinson D. Who fails to complete tuberculosis treatment? Temporal trends and risk factors for treatment interruption in a community-based directly observed therapy programme in a rural district of South Africa. Int J Tuberc Lung Dis 1999; 3: 1081-1087.
16. Beyers N, Gie R P, Schaaf H S, et al. Delay in the diagnosis, notification and initiation of treatment and compliance in children with tuberculosis. Tubercle Lung Dis 1994; 75: 260-265.
17. Cator M, Brassard P, Ducic S, Culman K. Facteurs associés à la non-observance du traitement de la tuberculose active, Montréal 1992-1995. Can J Public Health 2002; 93: 92-97.
18. Chauan L S, Arora V K, Central TB Division, Indian Academy of Pediatrics. Management of pediatric tuberculosis under the Revised National Tuberculosis Control Programme. Indian J Pediatr 2004; 71: 341-343.
19. Harries A D, Hargreaves N J, Graham S M, et al. Childhood tuberculosis in Malawi: nationwide case-finding and treatment outcomes. Int J Tuberc Lung Dis 2002; 6: 424-431.
20. Diniz L, Gerhardt G, Miranda J A, Manceau J N. Efetividade do tratamento da tuberculose em oito capitals brasileiras. Bol Pneum Sanit 1995; 3: 6-18.
21. Kritski A L, Gomes de Salles C L, Ferreira D, et al. Taxa de abandono do tratamento antituberculose. Pulmào 2002; 11: 9-15.
22. Deheinzelin D, Takagaki T Y, Sartori A M, Leite O H, Amato Neto V, de Carvalho C R. Fatores preditivos de abandono de tratamento por pacientes com tuberculose. Rev Hosp Clin Fac Med São Paulo 1996; 51: 131-135.
23. Oviawe O, Ojemudia E. The problem of non-attendance at a paediatric tuberculosis outpatient clinic. Ann Trop Paediatr 1993; 13: 243-247.
24. O'Boyle S J. Factors affecting patient compliance with antituberculosis chemotherapy using DOT short-course strategy. Int J Tuberc Lung Dis 2002; 6: 307-312.
25. Cuneo W D, Snider D E Jr. Enhancing patient compliance with tuberculosis therapy. Clin Chest Med 1989; 10: 375-380.
26. de Lima M B, Mello D A, Morais A P, da Silva W C. Estudo de casos sobre abandono do tratamento da tuberculose: avaliação do atendimento, percepção e conhecimento sobre a doença na perspectiva dos clientes (Fortaleza, Ceará, Brasil). Cad Saude Publica 2001; 17: 877-885.
27. Natal S, Valente J, Gerhardt G, Penna M L. Modelo de prediçã o para o abandono do tratamento da tuberculose pulmonar. Bol Pneumol Sanit 1999; 7: 65-78.
28. Caminero T M, Pavón J M, Rodrigues de Castro F, et al. Evaluation of a direct observed six month fully intermittent regimen for tuberculosis in patients suspected of poor compliance. Thorax 1996; 51: 1130-1133.
29. Oliveira H B, Moreira Filho D C. Abandono de tratamento e recidiva da tuberculose: aspectos de episódios prévios, Campinas, San Paolo, Brasil. Rev Saúde Pública 2000; 34: 437-443.
30. Chan-Yeung M, Noertjojo K, Leung C C, Chan S L, Tam C M. Prevalence and predictors of default from tuberculosis treatment in Hong Kong. Hong Kong Med J 2003; 9: 263-268.
31. Chee C B, Boudville I C, Chan S P, Zee Y K, Wang Y T. Patient and disease characteristics and outcome of treatment defaulters from the Singapore TB control unit-a one year retrospective survey. Int J Tuberc Lung Dis 2000; 4: 496-503.
32. McDonnell M, Turner J, Weaver M T. Antecedents of adherence to antituberculosis therapy. Public Health Nurs 2001; 18: 392-400.
33. Rodrigo T, Caylà J A, Galdós-Tangüis H, Garcia de Ollala P, Brugal M T, Jansá J M. Proposing indicators for evaluation of tuberculosis control programmes in large cities based on the experience of Barcelona. Int J Tuberc Lung Dis 2001; 5: 432-440.
34. World Health Organization. Global Tuberculosis Control. WHO Report 2004. Global tuberculosis control-surveillance, planning, financing. Country Profile-Brazil. WHO/HTM/TB/2004.331. Geneva, Switzerland: WHO, 2004. http://www.who.org
35. Secretaria Municipal de Saúde do Rio de Janeiro. Coordenação de Doenças Transmissíveis/Gerência de Pneumologia Sanitária. Rio-Estudos-Tuberculose. Rio de Janeiro, Brazil: Secretaria Municipal de Saúde, 2004.